Profile
Florian Fischer is the founder of MedVenture Partners GmbH, which was founded in 2002.
He held the position of Managing Director from 2002 to 2020.
Dr. Fischer also held former positions at AbCheck sro, Amphivena Therapeutics, Inc., Deutsche Bank AG, Affimed NV, KPMG LLP, Affimed NV Niederlassung Deutschland, Vivendy Therapeutics Ltd., and Vectura GmbH.
Dr. Fischer's education includes a doctorate from the University of Bielefeld and an undergraduate degree from Humboldt-Universität zu Berlin.
Former positions of Florian Fischer
| Companies | Position | End |
|---|---|---|
MedVenture Partners GmbH
MedVenture Partners GmbH Investment ManagersFinance Operates as a venture capital firm | Chief Executive Officer | 2020-02-02 |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Corporate Officer/Principal | 2020-02-01 |
| AFFIMED N.V. | Director of Finance/CFO | 2020-02-01 |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Director/Board Member | 2017-12-31 |
Vivendy Therapeutics Ltd.
Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Develops enzyme replacement therapy and biological products | Director of Finance/CFO | 2014-03-09 |
Training of Florian Fischer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Deutsche Bank AG
Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
AbCheck sro
AbCheck sro Packaged SoftwareTechnology Services Develops technology platform that discovers and optimizes human therapeutic antibodies | Technology Services |
Affimed NV
Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
University of Bielefeld
University of Bielefeld Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivendy Therapeutics Ltd.
Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Develops enzyme replacement therapy and biological products | Health Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
MedVenture Partners GmbH
MedVenture Partners GmbH Investment ManagersFinance Operates as a venture capital firm | Finance |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
- Stock Market
- Insiders
- Florian Fischer
















